drugset / Trial / NCT00006242

BMS-214662 in Treating Patients With Advanced Solid Tumors

NCT00006242

Phase 1 Completed 40 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of BMS-214662 in treating patients who have advanced solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die

Timeline

Start
2000-07
Primary completion
2005-09
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-214662 Small molecule Intravenous